Autoimmune manifestations associated with myelodysplastic syndromes Eric GrignanoVincent JachietArsène Mekinian Review Article 08 August 2018 Pages: 2015 - 2023
Predictors of clinical responses to hypomethylating agents in acute myeloid leukemia or myelodysplastic syndromes Hong WangYan LiLi Yu Review Article 06 August 2018 Pages: 2025 - 2038
Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study Diego V. CléElias H. AttaRodrigo T. Calado Original Article 05 July 2018 Pages: 2039 - 2046
Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus Zhangbiao LongFan YuBing Han Original Article 07 July 2018 Pages: 2047 - 2054
Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia Fahad A. S. Al-EidanSaud AlrawkanMark A. Crowther Original Article 12 July 2018 Pages: 2055 - 2059
Clinical outcome of granulocyte transfusion therapy for the treatment of refractory infection in neutropenic patients with hematological diseases Biqi ZhouTiemei SongYang Xu Original Article 08 August 2018 Pages: 2061 - 2070
The co-occurrence of driver mutations in chronic myeloproliferative neoplasms Prajwal BodduDai ChiharaSrdan Verstovsek Original Article 27 June 2018 Pages: 2071 - 2080
Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database Isao FujiokaTomoiku TakakuTatsuya Kawaguchi Original Article 26 June 2018 Pages: 2081 - 2088
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem? Santiago OsorioVicente Escudero-VilaplanaOn behalf of the CML Spanish Group (GELMC) Original Article 28 June 2018 Pages: 2089 - 2098
Profile of fibrosis-related gene transcripts and megakaryocytic changes in the bone marrow of myelodysplastic syndromes with fibrosis Kais HusseinAngelika Stucki-KochHans Kreipe Original Article 30 June 2018 Pages: 2099 - 2106
Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network Patrizia ZappasodiLaura MarbelloGiuseppe Rossi Original Article 15 July 2018 Pages: 2107 - 2115
Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016 Alexandar TzankovMarkus KremerKonnie M. Hebeda Original Article Open access 06 August 2018 Pages: 2117 - 2128
Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome? Charlott MörthAntonios ValachisGunilla Enblad Original Article Open access 08 August 2018 Pages: 2129 - 2135
The role of bortezomib in newly diagnosed diffuse large B cell lymphoma: a meta-analysis Zhijuan LinXing ChenBing Xu Original Article 19 July 2018 Pages: 2137 - 2144
In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment Csilla KristonMárk PlanderGábor Barna Original Article 28 June 2018 Pages: 2145 - 2152
Impact of age and comorbidities on the efficacy of FC and FCR regimens in chronic lymphocytic leukemia Vladimir StrugovElena StadnikAndrey Zaritskey Original Article 26 June 2018 Pages: 2153 - 2161
Low frequency of CD3+CD4+CD161+ T cells correlates with the occurrence of infections in refractory/relapsed multiple myeloma patients receiving lenalidomide plus low-dose dexamethasone treatment Sung-Eun LeeJi-Young LimChang-Ki Min Original Article 25 June 2018 Pages: 2163 - 2171
Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Takaaki KonumaShohei MizunoAdult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation Original Article 06 July 2018 Pages: 2173 - 2183
Efficacy of haploidentical hematopoietic stem cell transplantation compared to HLA-matched transplantation for primary refractory acute myeloid leukemia Bin GuXiang ZhangDepei Wu Original Article 23 July 2018 Pages: 2185 - 2194
Effects of preemptive interferon-α monotherapy in acute leukemia patients with relapse tendency after allogeneic hematopoietic stem cell transplantation: a case-control study Xiao-Ji LinHai-ping DaiXiao-Wen Tang Original Article 11 July 2018 Pages: 2195 - 2204
Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients Lucia BrunelloRoberto PasseraBenedetto Bruno Original Article 09 July 2018 Pages: 2205 - 2215
PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation Nazly SantosRocío Rodríguez-RomanosOn behalf of the GvHD/Immunotherapy Working Party of the Spanish Group of Hematopoietic Transplant (GETH) Original Article 17 July 2018 Pages: 2217 - 2224
Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies Sebastian ScheichSarah WeberBjörn Steffen Original Article 04 July 2018 Pages: 2225 - 2234
Fatigue at baseline is associated with geriatric impairments and represents an adverse prognostic factor in older patients with a hematological malignancy F. HoferK. A. KoinigR. Stauder Original Article Open access 28 July 2018 Pages: 2235 - 2243
Conviction in the face of affliction: a case series of Jehovah’s Witnesses with myeloid malignancies Rory M. ShallisMina L. XuAmer M. Zeidan Case Report 07 August 2018 Pages: 2245 - 2248
Severe anemia after trans-catheter arterial chemoembolization—an unusual presentation of hemoglobin Zurich Tanja BöhmeMichael MedingerAdrian Bachofner Letter to the Editor 08 May 2018 Pages: 2249 - 2251
Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab Junji HiragaAkihiro TomitaYoshitoyo Kagami Letter to the Editor 03 May 2018 Pages: 2253 - 2255
Would you think of histiocytic sarcoma in this fine-needle aspiration? Cristiano Claudino OliveiraJúlia Thalita Queiroz RochaMaria Aparecida Custódio Domingues Letter to the Editor 04 May 2018 Pages: 2257 - 2259
Hypertransaminasemia revealing a clinically silent muscular dystrophy in a child with sickle cell disease Naouel Guirat DhouibMonia Ben KhaledMohamed Bejaoui Letter to the Editor 12 May 2018 Pages: 2261 - 2262
Routine surveillance imaging in follicular lymphoma Marc SorigueJuan-Manuel Sancho Letter to the Editor 11 May 2018 Pages: 2263 - 2264
Localized pain-causing JAK2-V617F-positive myeloproliferation with normal peripheral blood values Magdalena M. GerlachChristian ArrantoAlexandar Tzankov Letter to the Editor 16 May 2018 Pages: 2265 - 2266
Drug-induced liver failure due to rivaroxaban Matthew PeverelleKhashayar AsadiMarie Sinclair Letter to the Editor 12 May 2018 Pages: 2267 - 2268